Evidence map›Paper›PMID 18276649›Full record

ArticleNucleic acids research2008

Secondary DNA structure formation for Hoxb9 promoter and identification of its specific binding protein.

Takumi Yamagishi, Shigehisa Hirose, Takashi Kondo

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Overexpression of HOXB9 promotes metastasis and indicates poor prognosis in colon cancer.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2014
    Article
  6. Article
  7. Histone demethylases and cancer.Advances in cancer research · 2009
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Takumi YamagishiKondo Research Unit, Brain Development Research Group, Brain Science Institute, Institute of Physical and Chemical Research (RIKEN), 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.
Shigehisa Hirose
Takashi Kondo
Tokyo Institute of Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hox genes determine anterior-posterior specificity of an animal body. In mammals, these genes map onto four chromosomal loci in a clustered manner, and their expression is regulated in a coordinated manner according to their chromosomal structure. In the present study, we analysed the Hoxb9 promoter and found that promoter activity in cultured cells is linked to secondary structure formation of promoter DNA. In nuclear extracts, we also detected binding activity specific for secondary-structured DNA. We successfully isolated a candidate gene encoding this specific DNA-binding protein, FBXL10, and demonstrated the effects of the gene product on Hoxb9 promoter activity. Our results suggest that DNA can regulate gene expression by other, non-sequence-specific modes of genetic coding.

Indexed as

Promoter Regions, GeneticAnimalsCell LineCell NucleusCloning, MolecularDNADNA-Binding ProteinsF-Box ProteinsHomeodomain ProteinsHumansJumonji Domain-Containing Histone DemethylasesMiceNucleic Acid ConformationOxidoreductases, N-DemethylatingProtein Structure, TertiaryRNA InterferenceDNADNA-Binding ProteinsF-Box ProteinsHomeodomain ProteinsHOXB9 protein, humanHoxb9 protein, mouseJumonji Domain-Containing Histone DemethylasesKDM2A protein, humanKdm2b protein, mouseOxidoreductases, N-Demethylating

Identifiers

PMID18276649
PMCPMC2330229
OpenAlexW2043997774

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.